Tuesday, 17 September 2019

Japan News

  • Taiho seeks Japanese nod for oral cancer agent

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidin...Read more

  • FDA approves Eisai's Fycompa

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (FDA) for the AMPA receptor antagonist Fycompa® (perampanel) as an adj...Read more

  • Innovative dual chamber syringe for pharma market

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new type of dual chamber prefillable syringe for freeze-dried pharmaceutical...Read more

  • Takeda to acquire LigoCyte Pharma

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have en...Read more

  • BioJapan to kick off in October

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: The 17th edition of BioJapan is all set to kick off from October 14, 2015 Pacifico Yokohama. Top industry players from more than 30 countries are expected to gather at the Asia's...Read more

  • Takeda, Resolve to develop, sell autoimmune drugs

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the treatment of lupus (also known as systemic lupus erythematosus or SLE)...Read more

  • Takeda acquires LigoCyte Pharmaceuticals at $60 mn

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment ...Read more

  • GlobalData: Osteoporosis market to be $8 bn

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more

  • R-Tech Ueno loses case against Takeda

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in the arbitration filed by R-Tech Ueno, together with Sucampo Pharmaceut...Read more

  • APAC ovarian cancer drug market to grow modestly'

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

  • Agenix gets patent for ThromboView in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Japan's Patent Office has granted a key patent to drug and diagnostic company Agenix covering the manufacturing process of its ThromboView imaging agent for the detection of bloo...Read more

  • Deal with Janssen gets Astellas $65 million up-front

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

    Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to develop and commercialize ASP015K, an Astellas compound, worldwide e...Read more

  • Scil Proteins, Ono collaborate to develop Affilin therapeutics

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Scil Proteins, a private biotech company specializing in the research, development and production of recombinant proteins, has signed a collaboration agreement with Ono Pharmaceu...Read more

  • Takeda acquires URL Pharma

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

    Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings (TAH), for an upfront payment of $800 million in cash and future per...Read more

  • Lorcaserin receives positive vote from FDA advisory committee

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to four, with one abstention, at a meeting held on ...Read more

  • Genetic diagnostics companies speed ahead

    Japan |  Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013

    The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US Supreme Court on June 13, 2013, stating that human genes cannot be p...Read more

  • Amgen CEO speaks of firm's grand entry into Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    The world's largest biotechnology company Amgen entered into a long-term collaboration with Astellas Pharma in May this year, and is set to form a joint venture in Tokyo, Amgen Astellas Bio...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls